Extended Data Table 5 Discrimination of Aβ positive vs negative participants in BioFINDER-1 (cohort 1)

From: Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer’s trial selection and disease monitoring

  1. AUC of two ROC curves were compared with DeLong test. Two-sided p-values were adjusted for multiple comparisons (n = 10) using Benjamini–Hochberg false discovery rate. Aβ status was defined based on CSF Aβ42/40 binarized using a threshold of 0.066 determined using mixture modelling.